- Home
- KROS vs JAKK Comparison
KROS vs JAKK Comparison
Compare KROS & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | JAKK |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.3M | 253.8M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | KROS | JAKK |
|---|---|---|
| Price | $10.75 | $21.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $21.86 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 312.7K | 40.2K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.65% |
| EPS Growth | ★ 146.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $243,864,000.00 | ★ $331,249,000.00 |
| Revenue This Year | N/A | $9.46 |
| Revenue Next Year | $2,751.79 | $4.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.79 | $14.87 |
| 52 Week High | $22.55 | $24.45 |
Technical Indicators
Market Signals| Indicator | KROS | JAKK |
|---|---|---|
| Relative Strength Index (RSI) | 42.74 | 47.39 |
| Support Level | $10.47 | $21.00 |
| Resistance Level | $12.43 | $23.00 |
| Average True Range (ATR) | 0.64 | 0.65 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 43.69 | 32.42 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells, and distributes toys and related kid-targeted consumer products, including kids' indoor and outdoor furniture, costumes, and various product lines in the sporting goods and home furnishings space. Its product offerings include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: Toys/Consumer Products and Costumes. It generates the majority of its revenue from the Toys/Consumer Products segment.